In summary, the multi-organ targeting strategies for HNF-1 provide multidimensional paradigms for renal disease research: extending classical drug mechanisms, multi-target interventions using natural products, and precision adaptation of gene-editing tools, collectively revealing therapeutic potential in renal lipid metabolism. The gene discussed is HNF1A; the disease is kidney disorder.